Buschulte, K.* ; Kabitz, H.J.* ; Hagmeyer, L.* ; Hammerl, P.* ; Esselmann, A.* ; Wiederhold, C.* ; Skowasch, D.* ; Stolpe, C.* ; Joest, M.* ; Veitshans, S.* ; Höffgen, M.* ; Maqhuzu, P.N. ; Schwarzkopf, L. ; Hellmann, A.* ; Pfeifer, M.* ; Behr, J.* ; Karpavicius, R.* ; Günther, A.* ; Polke, M.* ; Höger, P.* ; Somogyi, V.* ; Lederer, C.W.* ; Markart, P.* ; Kreuter, M.*
Hospitalisation patterns in interstitial lung diseases: Data from the EXCITING-ILD registry.
Respir. Res. 25:5 (2024)
BACKGROUND: Interstitial lung diseases (ILD) comprise a heterogeneous group of mainly chronic lung diseases with more than 200 entities and relevant differences in disease course and prognosis. Little data is available on hospitalisation patterns in ILD. METHODS: The EXCITING-ILD (Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases) registry was analysed for hospitalisations. Reasons for hospitalisation were classified as all cause, ILD-related and respiratory hospitalisations, and patients were analysed for frequency of hospitalisations, time to first non-elective hospitalisation, mortality and progression-free survival. Additionally, the risk for hospitalisation according to GAP index and ILD subtype was calculated by Cox proportional-hazard models as well as influencing factors on prediction of hospitalisation by logistic regression with forward selection. RESULTS: In total, 601 patients were included. 1210 hospitalisations were recorded during the 6 months prior to registry inclusion until the last study visit. 800 (66.1%) were ILD-related, 59.3% of admissions were registered in the first year after inclusion. Mortality was associated with all cause, ILD-related and respiratory-related hospitalisation. Risk factors for hospitalisation were advanced disease (GAP Index stages II and III) and CTD (connective tissue disease)-ILDs. All cause hospitalisations were associated with pulmonary hypertension (OR 2.53, p = 0.005). ILD-related hospitalisations were associated with unclassifiable ILD and concomitant emphysema (OR = 2.133, p = 0.001) as well as with other granulomatous ILDs and a positive smoking status (OR = 3.082, p = 0.005). CONCLUSION: Our results represent a crucial contribution in understanding predisposing factors for hospitalisation in ILD and its major impact on mortality. Further studies to characterize the most vulnerable patient group as well as approaches to prevent hospitalisations are warranted.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Hospitalisation ; Ild ; Ipf ; Prognosis ; Risk Factors; Idiopathic Pulmonary-fibrosis; Exacerbation; Update
Keywords plus
Language
english
Publication Year
2024
Prepublished in Year
0
HGF-reported in Year
2024
ISSN (print) / ISBN
1465-9921
e-ISSN
1465-993X
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 25,
Issue: 1,
Pages: ,
Article Number: 5
Supplement: ,
Series
Publisher
BioMed Central
Publishing Place
Campus, 4 Crinan St, London N1 9xw, England
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
80000 - German Center for Lung Research
30202 - Environmental Health
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-501800-533
G-505300-001
Grants
Helmholtz Centre Munich
InterMune (now Roche)
Copyright
Erfassungsdatum
2024-01-07